Literature DB >> 21536804

B cell maturation antigen deficiency exacerbates lymphoproliferation and autoimmunity in murine lupus.

Chao Jiang1, William M Loo, Erin J Greenley, Kenneth S Tung, Loren D Erickson.   

Abstract

Systemic lupus erythematosus and its preclinical lupus-prone mouse models are autoimmune disorders involving the production of pathogenic autoantibodies. Genetic predisposition to systemic lupus erythematosus results in B cell hyperactivity, survival of self-reactive B cells, and differentiation to autoantibody-secreting plasma cells (PCs). These corrupt B cell responses are, in part, controlled by excess levels of the cytokine BAFF that normally maintains B cell homeostasis and self-tolerance through limited production. B cell maturation Ag (BCMA) is a receptor for BAFF that, under nonautoimmune conditions, is important for sustaining enduring Ab protection by mediating survival of long-lived PCs but is not required for B cell maturation and homeostasis. Through analysis of two different lupus-prone mouse models deficient in BCMA, we identify BCMA as an important factor in regulating peripheral B cell expansion, differentiation, and survival. We demonstrate that a BCMA deficiency combined with the lpr mutation or the murine lupus susceptibility locus Nba2 causes dramatic B cell and PC lymphoproliferation, accelerated autoantibody production, and early lethality. This study unexpectedly reveals that BCMA works to control B cell homeostasis and self-tolerance in systemic autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21536804      PMCID: PMC3181142          DOI: 10.4049/jimmunol.1001931

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  58 in total

1.  Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches.

Authors:  Marilyn Thien; Tri Giang Phan; Sandra Gardam; Michelle Amesbury; Antony Basten; Fabienne Mackay; Robert Brink
Journal:  Immunity       Date:  2004-06       Impact factor: 31.745

2.  Reduced competitiveness of autoantigen-engaged B cells due to increased dependence on BAFF.

Authors:  Robin Lesley; Ying Xu; Susan L Kalled; Donna M Hess; Susan R Schwab; Hong-Bing Shu; Jason G Cyster
Journal:  Immunity       Date:  2004-04       Impact factor: 31.745

Review 3.  Murine models of systemic lupus erythematosus.

Authors:  A N Theofilopoulos; F J Dixon
Journal:  Adv Immunol       Date:  1985       Impact factor: 3.543

4.  CpG DNA induces IgG class switch DNA recombination by activating human B cells through an innate pathway that requires TLR9 and cooperates with IL-10.

Authors:  Bing He; Xugang Qiao; Andrea Cerutti
Journal:  J Immunol       Date:  2004-10-01       Impact factor: 5.422

5.  NF-kappa B1 p50 is required for BLyS attenuation of apoptosis but dispensable for processing of NF-kappa B2 p100 to p52 in quiescent mature B cells.

Authors:  Eunice N Hatada; Richard K G Do; Amos Orlofsky; Hsiou-Chi Liou; Michael Prystowsky; Ian C M MacLennan; Jorge Caamano; Selina Chen-Kiang
Journal:  J Immunol       Date:  2003-07-15       Impact factor: 5.422

6.  Mechanism of action of transmembrane activator and calcium modulator ligand interactor-Ig in murine systemic lupus erythematosus.

Authors:  Meera Ramanujam; Xiaobo Wang; Weiqing Huang; Lena Schiffer; Christine Grimaldi; Alla Akkerman; Betty Diamond; Michael P Madaio; Anne Davidson
Journal:  J Immunol       Date:  2004-09-01       Impact factor: 5.422

7.  TNF family member B cell-activating factor (BAFF) receptor-dependent and -independent roles for BAFF in B cell physiology.

Authors:  Yoshiteru Sasaki; Stefano Casola; Jeffery L Kutok; Klaus Rajewsky; Marc Schmidt-Supprian
Journal:  J Immunol       Date:  2004-08-15       Impact factor: 5.422

8.  Autoantibody-producing RP105(-) B cells, from patients with systemic lupus erythematosus, showed more preferential expression of BCMA compared with BAFF-R than normal subjects.

Authors:  Syuichi Koarada; Yoshifumi Tada; Yoshiaki Sohma; Yoshio Haruta; Rie Suematsu; Mio Mitamura; Hisako Inoue; Hiromi Ehara; Yusuke Tokoro; Akihide Ohta; Kohei Nagasawa
Journal:  Rheumatology (Oxford)       Date:  2010-01-22       Impact factor: 7.580

9.  Control of spontaneous B lymphocyte autoimmunity with adenovirus-encoded soluble TACI.

Authors:  Weimin Liu; Alex Szalai; Limin Zhao; Di Liu; Flavius Martin; Robert P Kimberly; Tong Zhou; Robert H Carter
Journal:  Arthritis Rheum       Date:  2004-06

10.  Short-lived plasmablasts and long-lived plasma cells contribute to chronic humoral autoimmunity in NZB/W mice.

Authors:  Bimba F Hoyer; Katrin Moser; Anja E Hauser; Anette Peddinghaus; Caroline Voigt; Dan Eilat; Andreas Radbruch; Falk Hiepe; Rudolf A Manz
Journal:  J Exp Med       Date:  2004-06-01       Impact factor: 14.307

View more
  19 in total

Review 1.  TNF superfamily in inflammatory disease: translating basic insights.

Authors:  Michael Croft; Wei Duan; Heonsik Choi; So-Young Eun; Shravan Madireddi; Amit Mehta
Journal:  Trends Immunol       Date:  2011-12-13       Impact factor: 16.687

Review 2.  Regulatory roles of the tumor necrosis factor receptor BCMA.

Authors:  Christine M Coquery; Loren D Erickson
Journal:  Crit Rev Immunol       Date:  2012       Impact factor: 2.214

Review 3.  BAFF inhibition in SLE-Is tolerance restored?

Authors:  Shaun W Jackson; Anne Davidson
Journal:  Immunol Rev       Date:  2019-09-28       Impact factor: 12.988

4.  A distinct plasmablast and naïve B-cell phenotype in primary immune thrombocytopenia.

Authors:  Shaun M Flint; Adele Gibson; Geoff Lucas; Raghava Nandigam; Louise Taylor; Drew Provan; Adrian C Newland; Caroline O Savage; Robert B Henderson
Journal:  Haematologica       Date:  2016-03-11       Impact factor: 9.941

Review 5.  The BAFF/APRIL system in SLE pathogenesis.

Authors:  Fabien B Vincent; Eric F Morand; Pascal Schneider; Fabienne Mackay
Journal:  Nat Rev Rheumatol       Date:  2014-03-11       Impact factor: 20.543

6.  BAFF regulates follicular helper t cells and affects their accumulation and interferon-γ production in autoimmunity.

Authors:  Christine M Coquery; William M Loo; Nekeithia S Wade; Annelise G Bederman; Kenneth S Tung; Janet E Lewis; Henry Hess; Loren D Erickson
Journal:  Arthritis Rheumatol       Date:  2015-03       Impact factor: 10.995

7.  Zoom Zoom: racing CARs for multiple myeloma.

Authors:  Marcela V Maus; Carl H June
Journal:  Clin Cancer Res       Date:  2013-02-26       Impact factor: 12.531

8.  Development of systemic lupus erythematosus in NZM 2328 mice in the absence of any single BAFF receptor.

Authors:  Chaim O Jacob; Ning Yu; Shunhua Guo; Noam Jacob; William J Quinn; Vishal Sindhava; Michael P Cancro; Beatrice Goilav; Chaim Putterman; Thi-Sau Migone; William Stohl
Journal:  Arthritis Rheum       Date:  2013-04

Review 9.  Clinical targeting of the TNF and TNFR superfamilies.

Authors:  Michael Croft; Chris A Benedict; Carl F Ware
Journal:  Nat Rev Drug Discov       Date:  2013-01-21       Impact factor: 84.694

10.  Mcl-1 is essential for the survival of plasma cells.

Authors:  Victor Peperzak; Ingela Vikström; Jennifer Walker; Stefan P Glaser; Melanie LePage; Christine M Coquery; Loren D Erickson; Kirsten Fairfax; Fabienne Mackay; Andreas Strasser; Stephen L Nutt; David M Tarlinton
Journal:  Nat Immunol       Date:  2013-02-03       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.